Literature DB >> 7690354

HTLV-I, HIV-I, and hepatitis B and C viruses in Western Province, Papua New Guinea: a serological survey.

K Yamaguchi1, T Inaoka, R Ohtsuka, T Akimichi, T Hongo, T Kawabe, M Nakazawa, M Futatsuka, K Takatsuki.   

Abstract

Seven hundred and twenty-three serum samples from individuals in 13 Gidra-speaking villages in Western Province, Papua New Guinea were tested for evidence of infection with human T-lymphotropic virus type I (HTLV-I), human immunodeficiency virus type I (HIV-I), hepatitis B virus (HBV) and hepatitis C virus (HCV). No samples were positive for antibodies to HIV-I. Antibodies to HTLV-I were found in 13 samples (1.8%), HBV surface antigens (HBsAg) were found in 86 samples (11.9%), and antibodies to HCV were found in 30 samples (4.1%). Six (46.2%) of 13 HTLV-I positive samples were positive for HCV or HBsAg. The seropositive rate varied in different villages and the incidence of HTLV-I and HCV was higher in coastal and riverine areas than inland.

Entities:  

Keywords:  Antibodies--analysis; Biology; Demographic Factors; Developing Countries; Diseases; Examinations And Diagnoses; Hepatitis; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Melanesia; Oceania; Papua New Guinea; Physiology; Population; Population Characteristics; Rural Population; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 7690354      PMCID: PMC5919200          DOI: 10.1111/j.1349-7006.1993.tb02034.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.

Authors:  Y Washitani; N Kuroda; H Shiraki; Y Nishimura; K Yamaguchi; K Takatsuki; L P Fernando; C T Fang; H Kiyokawa; Y Maeda
Journal:  Int J Cancer       Date:  1991-09-09       Impact factor: 7.396

3.  Australia antigen in Papua New Guinea.

Authors:  D G Woodfield; R E Oraka; M Nelson
Journal:  Med J Aust       Date:  1972-08-26       Impact factor: 7.738

4.  Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis.

Authors:  R Yanagihara; C L Jenkins; S S Alexander; C A Mora; R M Garruto
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

5.  A novel agglutination test for the human immunodeficiency virus antibody: a comparative study with enzyme-linked immunosorbent assay and immunofluorescence.

Authors:  T Yoshida; T Matsui; S Kobayashi; S Harada; T Kurimura; Y Hinuma; N Yamamoto
Journal:  Jpn J Cancer Res       Date:  1986-12

6.  Identification of gag and env gene products of human T-cell leukemia virus (HTLV).

Authors:  S Hattori; T Kiyokawa; K Imagawa; F Shimizu; E Hashimura; M Seiki; M Yoshida
Journal:  Virology       Date:  1984-07-30       Impact factor: 3.616

7.  Comparison between strains of human T lymphotropic virus type I isolated from inhabitants of the Solomon Islands and Papua New Guinea.

Authors:  R Yanagihara; V R Nerukar; A B Ajdukiewicz
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

8.  HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey.

Authors:  R J Brindle; R P Eglin; A J Parsons; A V Hill; J B Selkon
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

9.  Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea.

Authors:  R Yanagihara; V R Nerurkar; R M Garruto; M A Miller; M E Leon-Monzon; C L Jenkins; R C Sanders; P P Liberski; M P Alpers; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Authors:  R Fujino; K Kawato; M Ikeda; H Miyakoshi; M Mizukoshi; J Imai
Journal:  Jpn J Cancer Res       Date:  1991-04
View more
  4 in total

1.  Human herpesvirus-8 and other viral infections, Papua New Guinea.

Authors:  G Rezza; R T Danaya; T M Wagner; L Sarmati; I L Owen; P Monini; M Andreoni; B Suligoi; B Ensoli; E Pozio
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

2.  Hepatitis B surface antigen seroprevalence among children in Papua New Guinea, 2012-2013.

Authors:  Russel Kitau; Siddhartha Sankar Datta; Minal K Patel; Karen Hennessey; Kathleen Wannemuehler; Gerard Sui; William Lagani
Journal:  Am J Trop Med Hyg       Date:  2015-01-12       Impact factor: 2.345

3.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

4.  Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati.

Authors:  G L Abby Harrison; Jan Pryor; Joji Malani; Mathias Supuri; Andrew Masta; Burentau Teriboriki; Tebuka Toatu; David Penny; Jean-Pierre Allain; Eleanor Barnes; Oliver G Pybus; Paul Klenerman
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.